Stay updated on Metformin Chemoprevention in FAP: Clinical Trial
Sign up to get notified when there's something new on the Metformin Chemoprevention in FAP: Clinical Trial page.

Latest updates to the Metformin Chemoprevention in FAP: Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page now presents the record for a completed Phase 2 trial evaluating metformin versus placebo in patients with familial adenomatous polyposis, including its eligibility criteria, study design, outcomes, and publication details.SummaryDifference39%

- Check16 days agoChange DetectedThe footer revision identifier changes from v3.7.2 to v3.8.0 while the page continues to show a 403 Forbidden error.SummaryDifference0.3%

- Check23 days agoChange DetectedA banner announces that NIH content may use “Super Intelligence” instead of “Artificial Intelligence” during a terminology transition.SummaryDifference1%

- Check30 days agoChange DetectedThe revision label in the footer changes from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check37 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check58 days agoChange DetectedThe page now displays a 403 Forbidden message and the study details are removed from view, effectively hiding the previous trial description, eligibility criteria, outcomes, and history from the user.SummaryDifference17%

Stay in the know with updates to Metformin Chemoprevention in FAP: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Metformin Chemoprevention in FAP: Clinical Trial page.